5waw
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==FcAbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery== | |
| - | + | <StructureSection load='5waw' size='340' side='right'caption='[[5waw]], [[Resolution|resolution]] 2.25Å' scene=''> | |
| - | + | == Structural highlights == | |
| - | + | <table><tr><td colspan='2'>[[5waw]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5WAW OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5WAW FirstGlance]. <br> | |
| - | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.25Å</td></tr> | |
| - | [[ | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=GOL:GLYCEROL'>GOL</scene>, <scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
| - | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5waw FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5waw OCA], [https://pdbe.org/5waw PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5waw RCSB], [https://www.ebi.ac.uk/pdbsum/5waw PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5waw ProSAT]</span></td></tr> |
| - | [[ | + | </table> |
| - | [[Category: Convery | + | __TOC__ |
| + | </StructureSection> | ||
| + | [[Category: Homo sapiens]] | ||
| + | [[Category: Large Structures]] | ||
| + | [[Category: Convery M]] | ||
| + | [[Category: Reid RA]] | ||
| + | [[Category: Williams SP]] | ||
Current revision
FcAbVance: Increasing our knowledge of antibody structural space to enable faster and better decision-making in antibody drug discovery
| |||||||||||
